Our Pricing

How Lansoprazole and Omeprazole Work for Acid Reflux

Published on: June 03, 2026

Understanding lansoprazole vs omeprazole for acid reflux helps you make informed decisions about your treatment. Both are proton pump inhibitors (PPIs) licensed in the UK that reduce stomach acid production, but they differ in onset time, duration of action, and individual response rates. At Cured Pharmacy, our UK prescribers assess your symptoms to recommend the most suitable option, with transparent pricing from £9.99 and discreet delivery across the UK.

How Proton Pump Inhibitors Reduce Stomach Acid

Lansoprazole and omeprazole belong to the proton pump inhibitor class, which works by irreversibly blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells [1]. This enzyme, often called the 'proton pump', is responsible for the final step of acid secretion into the stomach. By inhibiting this mechanism, PPIs reduce gastric acid production by up to 90%, providing sustained relief from acid reflux symptoms [1].

Unlike antacids that neutralise existing stomach acid or H2 receptor antagonists that partially block acid production, PPIs offer the most potent acid suppression available. Clinical studies demonstrate that PPIs heal oesophageal erosions in approximately 80-90% of patients within 8 weeks, significantly higher than other treatment classes [2]. This makes them the gold standard for managing gastro-oesophageal reflux disease (GORD) and peptic ulcers in UK clinical practice.

Lansoprazole vs Omeprazole: Key Differences

Though both medications work through the same mechanism, lansoprazole and omeprazole exhibit distinct pharmacokinetic profiles that may influence treatment outcomes. Lansoprazole typically achieves peak plasma concentration within 1.5-2 hours, whilst omeprazole reaches peak levels in approximately 2-3 hours [3]. This slight difference in onset may benefit patients requiring faster symptom relief, though both provide sustained acid suppression lasting 24 hours.

Metabolic pathways also differ between these PPIs. Lansoprazole is metabolised primarily by CYP2C19 and CYP3A4 enzymes, whereas omeprazole relies more heavily on CYP2C19 alone [3]. This distinction matters for patients taking multiple medications, as drug interactions may vary. Genetic variations in CYP2C19 activity affect approximately 2-5% of the UK population, potentially reducing omeprazole's effectiveness in these individuals whilst lansoprazole maintains more consistent results [4].

Clinical efficacy studies show comparable healing rates between the two medications. A meta-analysis of 15 randomised controlled trials found no statistically significant difference in erosive oesophagitis healing between lansoprazole 30mg and omeprazole 20mg after 8 weeks of treatment [2]. However, individual patient response varies, and some people achieve better symptom control with one PPI over another due to genetic factors, concurrent medications, or disease severity.

Which PPI Works Faster for Acid Reflux?

Lansoprazole demonstrates a marginally faster onset of acid suppression compared to omeprazole, with some patients reporting symptom improvement within 24-48 hours. However, both medications require 3-5 days to achieve maximum acid-suppressing effect, as they must accumulate in parietal cells and bind to newly synthesised proton pumps [1]. Your UK prescriber will consider symptom severity and medical history when recommending initial treatment duration, typically 4-8 weeks for uncomplicated acid reflux.

Dosing and Administration for Acid Reflux

Standard dosing for acid reflux treatment differs slightly between these PPIs. Omeprazole is typically prescribed at 20mg once daily, taken 30 minutes before breakfast, whilst lansoprazole is usually given as 30mg once daily, also before the first meal [3]. Both medications are most effective when taken on an empty stomach, as food can reduce absorption and delay onset of action.

For severe symptoms or erosive oesophagitis, your prescriber may recommend higher doses or twice-daily administration. Omeprazole can be increased to 40mg daily, and lansoprazole to 30mg twice daily in refractory cases [2]. Treatment duration varies based on condition severity—uncomplicated GORD typically requires 4-8 weeks, whilst Barrett's oesophagus or severe erosive disease may necessitate long-term maintenance therapy at the lowest effective dose.

At Cured Pharmacy, we stock both Omeprazole Capsules from £9.99 and Lansoprazole Capsules from £9.99, with dosing recommendations determined during your free online consultation with a UK prescriber. All prescription medications require clinical assessment to ensure appropriate treatment selection and exclude serious underlying conditions.

Switching Between Lansoprazole and Omeprazole

If your current PPI isn't providing adequate symptom control, switching to an alternative proton pump inhibitor may improve outcomes. Approximately 10-20% of patients experience incomplete response to their initial PPI, often due to genetic variations in drug metabolism or incorrect timing of administration [4]. Your UK prescriber can recommend switching from omeprazole to lansoprazole (or vice versa) without a washout period, as cross-sensitivity between PPIs is extremely rare. Most patients notice whether the new medication is more effective within 2-4 weeks of switching.

Side Effects and Safety Considerations

Both lansoprazole and omeprazole are generally well-tolerated, with most patients experiencing no significant side effects. Common adverse effects include headache (affecting 2-7% of patients), nausea, diarrhoea, and abdominal pain [3]. These symptoms are typically mild and resolve without discontinuing treatment. Serious side effects are rare but include vitamin B12 deficiency with long-term use (over 3 years), increased fracture risk, and potential kidney problems in susceptible individuals [5].

Long-term PPI therapy requires periodic review by your healthcare provider. The MHRA recommends using the lowest effective dose for the shortest duration necessary to control symptoms [5]. Patients on maintenance therapy should have their treatment reviewed at least annually to assess ongoing need and consider step-down strategies, such as reducing dose or switching to on-demand therapy.

Drug interactions differ slightly between lansoprazole and omeprazole due to their metabolic pathways. Omeprazole can reduce the effectiveness of clopidogrel (a blood-thinning medication) by inhibiting its activation, whereas lansoprazole has minimal interaction with this drug [3]. Both PPIs may affect absorption of medications requiring acidic conditions, including certain antifungals, HIV medications, and iron supplements. Always inform your prescriber of all medications and supplements you're taking during your consultation.

Alternative Acid Reflux Treatments at Cured Pharmacy

Beyond lansoprazole and omeprazole, several other proton pump inhibitors are available through Cured Pharmacy for patients requiring alternative options. Esomeprazole is the S-isomer of omeprazole, offering more consistent acid suppression across different genetic profiles. Pantoprazole provides an alternative metabolic pathway with fewer drug interactions, making it suitable for patients on complex medication regimens.

Branded formulations may offer advantages for specific patient needs. Losec (branded omeprazole) and Nexium (branded esomeprazole) contain the same active ingredients as generic versions but may differ in excipients or formulation. Zoton FasTab is a lansoprazole formulation that dissolves on the tongue, beneficial for patients with swallowing difficulties.

For mild, occasional heartburn, Pyrocalm 20mg offers over-the-counter omeprazole for short-term relief. However, persistent symptoms lasting more than two weeks require medical assessment, as they may indicate GORD or other conditions requiring prescription-strength treatment. Our UK clinical team provides free consultations to determine the most appropriate acid reflux treatment based on your symptom severity, medical history, and concurrent medications.

When to Consider Prescription-Strength Treatment

Prescription-strength PPIs are indicated when over-the-counter options fail to control symptoms, when you experience heartburn more than twice weekly, or if you have alarm symptoms such as difficulty swallowing, unintended weight loss, or persistent vomiting [2]. These may indicate erosive oesophagitis, Barrett's oesophagus, or other conditions requiring higher doses and longer treatment courses. Your UK prescriber will assess symptom frequency, duration, and severity to recommend appropriate therapy and exclude serious underlying pathology requiring further investigation.

Getting Lansoprazole or Omeprazole from Cured Pharmacy

Accessing prescription acid reflux treatment through Cured Pharmacy is straightforward and completely discreet. Start by completing our free online consultation, which takes under 3 minutes and covers your symptoms, medical history, and current medications. A UK-registered prescriber reviews your assessment and, if appropriate, issues a prescription for the most suitable PPI based on your individual circumstances.

We offer transparent upfront pricing with no hidden fees—Omeprazole starts from £9.99, and Lansoprazole from £9.99. All medications are genuine UK-licensed products dispensed by our GPhC-registered pharmacy (registration number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). Your treatment arrives in 100% discreet packaging with fast UK delivery, and our clinical team remains available for ongoing support throughout your treatment journey.

If you're uncertain which PPI is right for you, our prescribers provide personalised recommendations during your consultation. Many patients successfully manage acid reflux with either lansoprazole or omeprazole, and the choice often depends on individual response, concurrent medications, and genetic factors. Should your initial treatment prove insufficient, we can adjust your prescription or recommend alternative options from our comprehensive range of acid reflux treatments.

Scientific References

1. Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current Gastroenterology Reports, 10(6), 528–534. https://doi.org/10.1007/s11894-008-0098-4 [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms for drug treatment. Expert Opinion on Drug Metabolism & Toxicology, 5(10), 1269–1282. https://doi.org/10.1517/17425250903160764 [accessed 13 August 2026]
3. Stedman, C. A. M., & Barclay, M. L. (2000). Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963–978. https://doi.org/10.1046/j.1365-2036.2000.00788.x [accessed 13 August 2026]
4. Furuta, T., et al. (2005). Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Annals of Internal Medicine, 139(12), 965–973. https://doi.org/10.7326/0003-4819-139-12-200312160-00006 [accessed 13 August 2026]
5. Medicines and Healthcare products Regulatory Agency. (2012). Proton pump inhibitors in long-term use: reports of hypomagnesaemia. Drug Safety Update, 5(11), A1. https://www.gov.uk/drug-safety-update/proton-pump-inhibitors-in-long-term-use-reports-of-hypomagnesaemia [accessed 13 August 2026]
6. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.